Tarsus Pharmaceuticals Inc (TARS) financials · rev $451.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Tarsus Pharmaceuticals Inc (TARS) rev $451.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $451.4M | $183.0M |
| Operating Income | -$71.0M | -$120.6M |
| Net Income | -$66.4M | -$115.6M |
| EPS (Diluted) | -$1.59 | -$3.07 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $562.2M | $377.0M |
| Current Assets | $522.8M | $356.7M |
| Cash & Equivalents | $183.6M | $94.8M |
| Inventory | $4.37M | $2.62M |
| PP&E | $11.7M | $2.31M |
| Total Liabilities | $218.7M | $152.5M |
| Current Liabilities | $135.7M | $80.6M |
| Long-term Debt | $72.4M | $71.8M |
| Total Debt | $72.4M† | $71.8M† |
| Shareholders' Equity | $343.4M | $224.5M |
| Retained Earnings | -$426.6M | -$360.2M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.5M | -$83.0M |
| CapEx | $9.86M | $1.57M |
| Investing Cash Flow | -$42.1M | -$199.2M |
| Financing Cash Flow | $143.4M | $154.7M |
| Net Change in Cash | $88.8M | -$127.6M |
| Free Cash Flow | -$22.3M | -$84.6M |
FAQ
What is TARS P/E and revenue?
Tarsus Pharmaceuticals Inc (TARS) rev $451.4M.
What is TARS revenue?
Tarsus Pharmaceuticals Inc last cached revenue is $451.4M (FY2025).
Is TARS profitable?
Tarsus Pharmaceuticals Inc last cached net income is -$66.4M (FY2025).
What are TARS total assets?
Tarsus Pharmaceuticals Inc last cached total assets are $562.2M (FY2025).
What is TARS free cash flow?
Tarsus Pharmaceuticals Inc last cached free cash flow is -$22.3M (FY2025).
Not investment advice. Cached statements, not a live tape.